Texas Business Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Business Times.

Press releases published on May 22, 2026

May 22, 2026

NANOBIOTIX annonce l’exercice integral de l’option de surallocation, portant le produit de l'offre a 100 millions de dollars

Indeterminate GlobeNewswire

May 22, 2026

ACP Holdings Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about May 28, 2026

Indeterminate GlobeNewswire

May 22, 2026

Japan Smaller Capitalization Fund, Inc. Announces Commencement of Tender Offer and Re-Leveling of Level Distribution Plan

Indeterminate GlobeNewswire

May 22, 2026

Maris-Tech Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance

Indeterminate GlobeNewswire

May 22, 2026

Orange County Bancorp, Inc. Declares Cash Dividend

Indeterminate GlobeNewswire

May 22, 2026

XTL Announces Receipt of Staff Delist Determination from Nasdaq

Indeterminate GlobeNewswire

May 22, 2026

Mission Produce and Calavo Growers Merger Obtains Mexican Antitrust Approval

Indeterminate GlobeNewswire

May 22, 2026

VITAL FARMS DEADLINE MAY 26th: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Vital Farms, Inc. and Encourages Investors to Contact the Firm

Indeterminate GlobeNewswire

May 22, 2026

Rural America Has Been Left Behind for Decades. Ex-Wall Street Expert Says That Era Is Finally Ending

Indeterminate GlobeNewswire

May 22, 2026

IMMUNITYBIO CLASS ACTION DEADLINE TUESDAY MAY 26th: Bragar Eagel & Squire, P.C. Urges Immunity Bio, Inc. Stockholders with Significant Losses to Contact the Firm Regarding Their Rights Before May 26th

Indeterminate GlobeNewswire

May 22, 2026

Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis

Indeterminate GlobeNewswire

May 22, 2026

Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH

Indeterminate GlobeNewswire

May 22, 2026

Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026

Indeterminate GlobeNewswire

May 22, 2026

Dynagas LNG Partners LP Announces Date for the Release of the First Quarter 2026 Results

Indeterminate GlobeNewswire

May 22, 2026

E-Power Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Indeterminate GlobeNewswire

May 22, 2026

ContextLogic Holdings Inc. Publishes Q&A Following First Quarter 2026 Results

Indeterminate GlobeNewswire

May 22, 2026

E.F. Hutton & Co. Serves as Sole Placement Agent on HCW Biologics Inc. $4.0 Million Private Placement

Indeterminate GlobeNewswire

May 22, 2026

Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 22, 2026

All In FutureTech Alliance Long-Term Strategic Direction Following the HyalRoute Acquisition: Building a Future Technology Platform Driven by AI Infrastructure and AI Applications, with Optical Technologies at Its Core

Indeterminate GlobeNewswire

May 22, 2026

92% of EU 2026 World Cup Bettors Have Wagered on a Previous Tournament, According to Optimove Insights Report

Indeterminate GlobeNewswire